The Cancer|Drug Shortage Is Different

93 percent of US cancer centers said they were experiencing a shortage of the drug carboplatin, while 70 percent were low on another, cisplatin.

The cisplatin drug shortage in 2023 led to an increased use of alternative drugs and higher costs for people with head and neck cancers, ...

Primary causes of the cancer drug shortage include manufacturing issues, supply chain disruptions, and regulatory delays.

The US is facing shortages of more than a dozen cancer drugs, as well as hundreds of other medications, including antibiotics.

This included carboplatin and cisplatin — two common, injectable chemotherapy drugs used to treat breast cancer and other cancers. Some cancer ...

Hospital staff have grown accustomed to scrambling when a pediatric cancer drug is in shortage. They call other hospitals to see if they have ...

Drug shortages are a long-standing headache for hospitals, but the breadth and duration of the ongoing shortage in what another expert calls “ ...

The centers that participated in the survey also reported that several other key cancer medications are currently in short supply, with 46% ...

Recently, we've been hearing about the serious shortage of certain widely used cancer drugs. For people whose cancer treatment depends on ...

The nation's drug shortage crisis continues to affect cancer ... Click on the different category headings to find out more and change our default ...

And shortages are occurring frequently, as the Food and Drug Administration (FDA) has reported between 30 and 50 new drug shortages per year.

Prescription drug shortages began to increase markedly in the mid-2000s, including sterile injectable products such as chemotherapy drugs.

COVID-19 also shuttered Chinese factories that manufactured drug ingredients. Then the supply of several chemo drugs dried up after Indian ...

The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market.

Carlson sees warning signs about other drugs, too. The drug 5FU, commonly used to treat colorectal cancer, was in shortage at 26% of the cancer ...

Four of the 20 essential cancer medicines are currently in shortage, according to the FDA. Analysis leveraging USP's Medicine Supply Map ...

Meanwhile, shortages of vinblastine and dacarbazine have become a concern.1-5. “[V]inblastine, dacarbazine, and methotrexate are essential for ...

Last year, oncologists dealt with the most severe cancer drug shortage to date. Over about 6 months in 2023, cancer centers across the ...

In October 2023, the Food and Drug Administration (FDA) changed the status of Pluvicto from “currently in shortage” to “shortage resolved” ...

Widespread shortages of cancer drugs, including widely used carboplatin, are forcing doctors to make difficult decisions about how to treat ...